References
Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248–58.
Kanumuri P, Hayse B, Killelea BK, Chagpar AB, Horowitz NR, Lannin DR. Characteristics of multifocal and multicentric breast cancers. Ann Surg Oncol. 2015;22:2475–82.
Lynch SP, Lei X, Chavez-MacGregor M, et al. Multifocality and multicentricity in breast cancer and survival outcomes. Ann Oncol. 2012;23:3063–9.
Sparano JA, Gray RJ, Makower DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018;379:111–21.
Grabenstetter A, Brogi E, Chou JF, et al. Multifocal/multicentric ipsilateral invasive breast carcinomas with similar histology: is multigene testing of all individual foci necessary? Ann Surg Oncol. 2019;26:329–35.
Pawloski, KR, Wen HY, Tadros AB, et al. Concordance between 21-gene recurrence scores in multifocal or multicentric breast carcinomas differs by age and histologic subtype. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-020-09429-y.
Funding
Funding was provided by NIH/NCI Cancer Center Support Grant (Grant No. P30 CA008748).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Dr. Kate R. Pawloski, Dr. Audree B. Tadros, and Dr. Mahmoud El-Tamer declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pawloski, K.R., Tadros, A.B. & El-Tamer, M. ASO Author Reflections: Age Is an Important Determinant of Concordance Between 21-Gene Recurrence Scores in Multiple Ipsilateral Breast Carcinomas. Ann Surg Oncol 28, 4263–4264 (2021). https://doi.org/10.1245/s10434-020-09443-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-09443-0